SIEMENS HEALTHINEERS AG

(SHL)
  Report
Delayed Xetra  -  11:35 2022-08-12 am EDT
51.66 EUR   -1.11%
08/08SIEMENS HEALTHINEERS AG : Release of a capital market information
EQ
08/05SIEMENS HEALTHINEERS AG : Notification and public disclosure of transactions by persons
EQ
08/05SIEMENS HEALTHINEERS AG : Notification and public disclosure of transactions by persons
EQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: September 2019 2020 2021 2022 2023 2024
Capitalization1 36 06741 08863 05357 842--
Enterprise Value (EV)1 39 24145 97974 12169 89868 30766 985
P/E ratio 23,0x27,4x35,8x28,8x26,2x22,1x
Yield 2,22%2,09%1,51%1,85%2,03%2,35%
Capitalization / Revenue 2,48x2,84x3,50x2,73x2,64x2,48x
EV / Revenue 2,70x3,18x4,12x3,30x3,12x2,87x
EV / EBITDA 13,4x16,4x20,5x16,5x15,1x13,1x
Price to Book 3,69x3,07x3,79x3,35x3,19x2,97x
Nbr of stocks (in thousands) 999 2231 072 7981 122 3351 119 661--
Reference price (EUR) 36,138,356,251,751,751,7
Announcement Date 11/04/201911/02/202011/04/2021---
1 EUR in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: September 2019 2020 2021 2022 2023 2024
Net sales1 14 51814 46017 99721 17021 88923 339
EBITDA1 2 9202 7963 6124 2414 5335 128
Operating profit (EBIT)1 2 3002 2303 1423 5603 7664 286
Operating Margin 15,8%15,4%17,5%16,8%17,2%18,4%
Pre-Tax Profit (EBT)1 2 1931 9542 4042 8573 1313 701
Net income1 1 5671 4111 7272 0162 1972 604
Net margin 10,8%9,76%9,60%9,52%10,0%11,2%
EPS2 1,571,401,571,801,972,33
Dividend per Share2 0,800,800,850,961,051,21
Announcement Date 11/04/201911/02/202011/04/2021---
1 EUR in Million
2 EUR
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: September 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4
Net sales1 5 1645 0685 46010 5285 1865 545
EBITDA1 --1 116-9381 151
Operating profit (EBIT)1 7938989801 879765932
Operating Margin 15,4%17,7%17,9%17,8%14,8%16,8%
Pre-Tax Profit (EBT) -661----
Net income1 462466579-363515
Net margin 8,95%9,19%10,6%-7,00%9,28%
EPS2 0,410,410,51-0,320,47
Dividend per Share ------
Announcement Date 11/04/202102/03/202205/04/202205/04/202208/03/2022-
1 EUR in Million
2 EUR
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: September 2019 2020 2021 2022 2023 2024
Net Debt1 3 1744 89111 06812 05710 4659 143
Net Cash position1 ------
Leverage (Debt / EBITDA) 1,09x1,75x3,06x2,84x2,31x1,78x
Free Cash Flow1 1 0381 3712 2591 6522 4062 641
ROE (Net Profit / Equities) 17,0%14,3%15,5%14,3%14,4%15,5%
Shareholders' equity1 9 2139 86511 14214 14315 29816 818
ROA (Net Profit / Asset) 7,61%6,07%6,64%5,25%5,19%6,20%
Assets1 20 59423 26226 00938 39542 29841 970
Book Value Per Share2 9,7912,514,815,416,217,4
Cash Flow per Share2 1,621,912,672,452,762,95
Capex1 579557674843890942
Capex / Sales 3,99%3,85%3,75%3,98%4,07%4,04%
Announcement Date 11/04/201911/02/202011/04/2021---
1 EUR in Million
2 EUR
Previous periodNext period
Estimates
Key data
Capitalization (EUR) 57 841 684 677
Capitalization (USD) 59 306 556 626
Net sales (EUR) 17 997 000 000
Net sales (USD) 18 452 783 759
Number of employees 66 000
Sales / Employee (EUR) 272 682
Sales / Employee (USD) 279 588
Free-Float 24,2%
Free-Float capitalization (EUR) 13 984 716 130
Free-Float capitalization (USD) 14 338 886 630
Avg. Exchange 20 sessions (EUR) 45 497 987
Avg. Exchange 20 sessions (USD) 46 650 249
Average Daily Capital Traded 0,08%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA